Team Research Forum February 24 at 10:30am. Cancer Prevention for Marginalized Women

Team Research Forum: Cancer Prevention for Marginalized Women

Team Research Forum: Cancer Prevention for Marginalized Women

Join the UC Davis Office of Research and UC Davis Health at 10:30am on Friday, February 24th to learn more about the cancer center’s new mobile mammography van that will soon serve marginalized and hard to reach communities, increasing access to breast cancer screening and diagnostic services.  Part of a new study conducted by cancer researchers Diana Miglioretti and Laura Fejerman, the program will also serve as a data collection hub for health equity research and use leading-edge genomics and artificial intelligence to predict breast cancer risk.

Focused on racially/ethnically diverse low-income women, the UC Davis Cancer Center’s precision breast cancer screening research program is one of four UC Davis Health programs funded as part of a new UC Davis initiative is known as the HEAL-HER (Heart, BrEast and BrAin Heath Equity Research) Program.  HEAL-HER is supported by a $24 million award to UC Davis Health for women’s health research in breast cancer, dementia and cardiovascular disease.

 

Register for this event

 

diana miglioretti portraitDianna Miglioretti
Professor and Division Chief of Biostatistics

Dr. Miglioretti’s primary methodological research interests are in multilevel and latent variable models, longitudinal and clustered data analysis, and the evaluation of screening and diagnostic tests. The majority of her collaborative research is in the areas of breast cancer screening and radiation exposure from medical imaging.

 

laura fejerman portraitLaura Fejerman
Associate Professor, Department of Public Health Sciences
Co-director Women’s Cancer Care Program, UC Davis Comprehensive Cancer Center

Dr. Fejerman’s research focuses on the discovery and understanding of genetic and environmental factors that contribute to breast cancer risk and survival and that could be used as targets for prevention and therapy. Specifically, her lab investigates factors contributing to breast cancer incidence and survival in women who self-identify as Hispanic/Latina in the US and Latin American women.